Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 16, 2014
Aprepitant and fosaprepitant use in children and adolescents at an academic medical centerAlexandra Shillingburg, Lisa Biondo
The Journal of Community and Supportive Oncology|February 10, 2016
Drug-induced immune hemolytic anemia associated with albumin-bound paclitaxelRoby Thomas, Alexandra Shillingburg
Chemotherapy Research and Practice|November 26, 2015
Oral Antineoplastic Agents: Assessing the Delay in CareBrandi Anders, Alexandra Shillingburg, Michael Newton
Pediatric Blood & Cancer|December 21, 2013
Safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in pediatric patients: a prospective, observational studyMegan Bodge, Alexandra Shillingburg, Stephan Paul, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 27, 2019
Women in oncology pharmacy leadership: A white paperAlexandra Shillingburg, Laura B Michaud, Rowena Schwartz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 13, 2017
Treatment of severe mucositis pain with oral ketamine mouthwashAlexandra Shillingburg, Abraham S Kanate, Mehdi Hamadani, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 30, 2019
Front-line use of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: Practice considerationsMichael J Reff, Alexandra Shillingburg, Bhavesh Shah, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2016
Impact of intravenous magnesium infusion rate during ambulatory replacements on serum magnesium concentrations after allogeneic stem cell transplantMatthew Snyder, Alexandra Shillingburg, Michael Newton, et al.
Advances in Hematology|June 8, 2017
Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid LeukemiaBrandi Anders, Lauren Veltri, Abraham S Kanate, et al.
Pageof 2